clinical trial

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The UK has given the go-ahead to a SARS-CoV-2 human challenge trial, Reuters reports.

University of Oxford researchers are investigating whether combining different COVID-19 vaccines provides the same or better protection than one type of vaccine alone, Business Insider says.

A new preprint reports Russia's Sputnik V vaccine is safe and effective against COVID-19, according to the Associated Press.

Johnson & Johnson reports interim results from a Phase 1/2 study of its SARS-CoV-2 vaccine in the New England Journal of Medicine, according to Bloomberg.

A monoclonal antibody treatment from Eli Lilly may slow the progression of Alzheimer's disease, the New York Times reports.

Novavax is launching a late-stage clinical trial of its prospective SARS-CoV-2 vaccine in the US and Mexico, according to the Financial Times.

Early trial data of a Sanofi and GlaxoSmithKline SARS-CoV-2 vaccine indicates an insufficient immune response among older participants, according to Reuters.